Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Biologics for severe asthma have known side effects, but some new risks need more study.

Tofacitinib might be used to treat hair loss.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.